pharmaceutical investing UroGen Pharma Submits Investigational New Drug (IND) Application for UGN-102 (VesiGel)
Element79 Gold Corp Announces Corporate Update and Strategic Leadership Changes With Focus On Accelerating Nevada Asset Development